

View larger version (157K):
[in a new window]
|
Figure 1. A 30-year-old woman, 10 years after radical hysterectomy and bilateral ovarian transposition for carcinoma of the cervix, referred for PET/CT for suspected recurrence on MRI (patient no. 4). (a) An axial T2 weighted MR image at the pelvic inlet shows the transposed right ovary (RO) anteriorly to the ascending colon (AC) as a 5 cm hyperintense mass with a thin hypointense rim, suspected to be a necrotic tumour recurrence. Note also the left transposed ovary (LO), abutting the anterior aspect of the descending colon (DC), as a hypointense lesion. That ovary was not reported on the MRI. (b) Axial PET/CT images (from left to right: CT, PET and fused PET/CT images). On the CT, the bilateral transposed ovaries are seen (thin white arrows). Note the diminution in size of the right ovary in comparison with the previous MRI performed 1 month earlier, most likely related to its periodic functional changes. The left transposed ovary shows increased FDG uptake on the PET and on fused images (thin arrows). Additional physiological sites of FDG uptake are seen, including bowel (arrowhead), bone marrow (medium-size arrow) and iliac blood vessels (large arrow). (c) Coronal PET-CT images (from left to right: CT, PET and fused PET/CT images) show mild increased FDG uptake in the left transposed ovary (arrows). Physiological FDG uptake is seen in the brain, myocardium, bowel and liver.
|